COMMUNIQUÉS West-GlobeNewswire

RenovoRx Secures First Notice of Allowance for Japanese Patent Covering its RenovoCath® Device for Targeted, Local Drug-Delivery via the Vasa Vasorum
08/04/2026
Patent Expands Protection for the Company’s RenovoCath Device, the Novel Dual-Occlusion Catheter-Based System RenovoRx Currently Holds a Strong and Growing Global Intellectual Property Portfolio with 19 Issued or [...]
New Data from Week 52 of the Ongoing COACH Trial Showed that TransCon® hGH Accelerated TransCon® CNP’s Benefits Beyond Linear Growth in Children with Achondroplasia
08/04/2026
- Unprecedented improvements in arm span observed with TransCon CNP and TransCon hGH combination therapy, a measure highly meaningful to the achondroplasia community - Enhanced improvements in spinal canal dimensions [...]
Medline to report first quarter 2026 results on May 6, 2026
08/04/2026
NORTHFIELD, Ill., April 08, 2026 (GLOBE NEWSWIRE) -- Medline Inc. (“Medline”) (Nasdaq: MDLN) today announced that it plans to report first quarter 2026 financial results on Wednesday, May 6, 2026. A press release and [...]
Palisade Bio to Present at the Needham & Co. 25th Annual Healthcare Conference
08/04/2026
Virtual presentation scheduled for Thursday, April 16th at 2:15 PM ET Access the webcast here Denver, CO, April 08, 2026 (GLOBE NEWSWIRE) -- Palisade Bio, Inc. (Nasdaq: PALI) (“Palisade” or the “Company”), a clinical- [...]
Psyence BioMed Expands Australian Clinical Site Network to Five Sites, Advancing NPX-5–Supported Clinical Activities
08/04/2026
Expansion supports accelerated enrollment and advancement of the Company’s lead clinical asset NEW YORK, April 08, 2026 (GLOBE NEWSWIRE) -- Psyence Biomedical Ltd. (Nasdaq: PBM) (“Psyence BioMed” or the “Company”), a [...]
Longeveron Granted Chinese Patent for Potency Assay Methods for Assessing Human Mesenchymal Stem Cells (MSCs)
08/04/2026
The patent relates to potency assay methods for assessing human mesenchymal stem cells (MSCs) derived from bone marrow, adipose tissue, peripheral blood, a lung, a heart, amniotic fluid, inner organs, an amniotic [...]
Ritedose Announces Manufacturing for Tenpoint Therapeutics’ Presbyopia Eye Drop
08/04/2026
Partnership Signals Commercial Readiness and Manufacturing Strength for Groundbreaking Ophthalmic Treatment COLUMBIA, S.C., April 08, 2026 (GLOBE NEWSWIRE) -- The Ritedose Corporation, Inc. (Ritedose), the largest [...]
Catheter Precision to Attend the Annual European Heart Rhythm Association Conference
08/04/2026
FORT MILL, S.C., April 08, 2026 (GLOBE NEWSWIRE) -- Catheter Precision, Inc. (NYSE American: VTAK) (“VTAK” or the “Company”) today announced that it will be attending the annual European Heart Rhythm Association (EHRA) [...]
TOMI Environmental Solutions, Inc. Announces Unaudited Preliminary Financial Results for Q1 2026 Revenue Reflecting Strong Sequential Revenue Growth Over Q4
08/04/2026
FREDERICK, Md., April 08, 2026 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc. ® (“TOMI”) (NASDAQ: TOMZ), a global leader in disinfection and decontamination solutions is pleased to announce that its preliminary [...]
ProQR Announces Partnership with Ginkgo Bioworks and Formation of AI Advisory Board
08/04/2026
ProQR and Ginkgo Bioworks to collaborate on autonomous lab high throughput data generation to support ProQR’s AI-enabled drug discovery for Axiomer™ ProQR establishes AI Advisory Board with leaders from industry and [...]
Tekton Research Opens First Multi-Specialty Clinical Research Hub in San Antonio
08/04/2026
As First Hub Opens, Tekton Adds New Principal Investigator, Dr. Arti Thangudu, and Expands Patient Access to Clinical Research AUSTIN, Texas, April 08, 2026 (GLOBE NEWSWIRE) -- Tekton Research , a leading multi-site [...]
American College of Cardiology (ACC) Scientific Sessions 2026 Underscore the Need for Complementary Therapies Including Icosapent Ethyl (IPE) in Treatment of Elevated Triglycerides and Cardiovascular Risk Reduction
08/04/2026
DUBLIN and BRIDGEWATER, N.J., April 08, 2026 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ: AMRN) (“Amarin”), a company committed to advancing the science of cardiovascular disease (CVD) worldwide, today [...]
Ondo Global Markets Tokenizes Enlivex’s Ordinary Shares
08/04/2026
Nes-Ziona, Israel, April 08, 2026 (GLOBE NEWSWIRE) -- Enlivex Ltd. (Nasdaq: ENLV, “Enlivex” or the “Company”), a quality longevity company powered by a prediction markets treasury, today announced that Ondo Finance (“ [...]
Aclaris Therapeutics to Participate in the H.C. Wainwright 4th Annual Inflammatory Skin Disease Virtual Conference
08/04/2026
WAYNE, Pa., April 08, 2026 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on developing novel product candidates for immuno-inflammatory diseases, today [...]
Le Canada néglige les millions de personnes qui vivent avec l’arthrite, mais un plan audacieux vise à éradiquer la maladie
08/04/2026
Action immédiate contre l’arthrite réunit 21 organisations, plus de 100 000 patients, des chercheurs, des cliniciens et des défenseurs de la cause afin de transformer la recherche sur l’arthrite et les soins au Canada [...]
NewAmsterdam Pharma to Present at the 25th Annual Needham Virtual Healthcare Conference
08/04/2026
NAARDEN, the Netherlands and MIAMI, April 08, 2026 (GLOBE NEWSWIRE) -- NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS or “NewAmsterdam” or the “Company”), a late-stage, clinical biopharmaceutical company developing oral [...]
Precision Neuroscience™ Appoints Craig Mermel as Chief AI and Data Officer
08/04/2026
As brain–computer interfaces advance, neural data emerges as a key asset. NEW YORK, April 08, 2026 (GLOBE NEWSWIRE) -- Precision Neuroscience Corporation (Precision), a leading brain–computer interface (BCI) company, [...]
Artiva Biotherapeutics to Participate in the 25th Annual Needham Virtual Healthcare Conference
08/04/2026
SAN DIEGO, April 08, 2026 (GLOBE NEWSWIRE) -- Artiva Biotherapeutics, Inc. (Nasdaq: ARTV), a clinical-stage biotechnology company whose mission is to develop effective, safe and accessible cell therapies for patients [...]
Life Biosciences Secures $80 Million Series D Financing
08/04/2026
Funding to support the Phase 1 clinical trial of ER-100 in optic neuropathies and further investigation of new candidates from the company’s Partial Epigenetic Reprogramming platform BOSTON, April 08, 2026 (GLOBE [...]

Pages